top of page
Image-empty-state.png

Evelina Tacconelli

Director

Email:

Phone:

+39 045 812 8243

Short biography

Evelina Tacconelli is a Full Professor of Infectious Diseases at the University of Verona, Italy and Head of the DZIF Clinical Research Unit on healthcare associated infections and antimicrobial resistance at the Tübingen University, Germany. She has been Lecturer on Medicine at the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA. She was recipient of award from the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for research excellence. Consultant for WHO, ECDC and EMA on antimicrobial resistance and infection control. Her main areas of scientific interest are epidemiology, clinical and therapeutic aspects of healthcare-associated infections and preventive measures aimed to reduce the spreading of antibiotic-resistant bacteria. Co-coordinator of the Unit of research on healthcare-associated and antibiotic-resistant bacterial infections (TTU-HAARBI) within the German Center for Infectious Diseases (DZIF). She is the ESCMID Guideline Officer for Infectious Diseases and Clinical Microbiology. Member of the SAB of the JPI-AMR. Chair of the 2018 WHO Priority List of Pathogens for R&D of new antibiotics. Chair of the European Committee of Infection Control (EUCIC). Chair of the ESCMID guidelines on prevention and therapy of infections due to multidrug-resistant Gram negative bacteria (MDR-GN) and EUCIC guideline on decolonization procedures for patients colonized with MDR-GN. Involved (partner site or coordinator) in many European studies on prevention and therapy of infections caused by antibiotic-resistant bacteria financed by European Commission, WHO, JPI-AMR, Horizon2020, DG-Sanco, IMI, and DZIF. She serves on the International Advisory Board of Lancet Infectious Diseases, Editorial Board of Journal of Antimicrobial Chemotherapy and Scientific Committee of Clinical Microbiology and Infection. Author and co-author of more than 200 papers listed in SCI-JCR and NIH Medline. In April 2023 Evelina was appointed as Chief Scientific Officer (CSO) of the Ecraid Foundation.

Projects

ORCHESTRA

PIPELINE

PRIMAVERA

ENACT-REACT COVID (LTFU)

ARCH-NET

ECRAID-Base

EU-RESPONSE

EPI-Net

WHO BPPL

SOLIDARITY-Italy

ENACT-REACT COVID (RA)

MPX-RESPONSE

AMR Travel Tool

VACCELERATE

ENACT-SOS COVID

COMBACTE-NET-EXPECT

PROACT EU-Response

Excellence Centres

VALUE-DX

Sentinella

ENACT-REACT COVID (MS)

Chemsex MSM

Publications

27/03/25

Communications Medicine

Long-term immune responses to SARS-CoV-2 Omicron BA.4/5 mRNA booster in people living with HIV

04/03/25

Clinical Microbiology and Infection

ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Rheumatological Patients

24/03/25

Archives of Public Health

Short-term acute outcomes by clinical and socioeconomic characteristics in adults with SARS-CoV-2: a population-based cohort study focused on the first two years of the COVID-19 pandemic

01/03/25

The Journal of Hospital Infection

Revisiting Antimicrobial Stewardship in the Paediatric Intensive Care Unit: Insights from an Unconventional Approach

13/03/25

Eurosurveillance

Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022

13/02/25

Clinical Microbiology and Infection

ORCHESTRA Delphi Consensus: Diagnostic and Therapeutic Management of SARS-CoV-2 Infection in Solid Organ Transplant Recipients

LOGO IDCARE bianco.png
  • Twitter
  • LinkedIn

Borgo Roma-Policlinico G.B. Rossi, Piazzale Antonio Ludovico Scuro, 10, 37134, Verona, Italy.

Borgo Trento-Ospedale Borgo Trento Piazzale Aristide Stefani, 1 - 37126, Verona, Italy

+39 045 8128243

Copyright © 2024 ID-Care.

bottom of page